Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Recruiting
1,100 enrolled
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer
Active not recruiting
1,336 enrolled
National Cancer Institute "Cancer Moonshot Biobank"
Active not recruiting
1,600 enrolled
TraveraRTGx
Completed
72 enrolled
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Recruiting
1,000 enrolled
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
Completed
140 enrolled
ASAP
Recruiting
25,000 enrolled
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Suspended
22 enrolled
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Recruiting
25 enrolled
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
Completed
64 enrolled
iCaRe2
Recruiting
999,999 enrolled
EXoPERT EMERALD Clinical Study
Recruiting
1,400 enrolled
CAMPERR
Recruiting
7,000 enrolled
SCORE
Recruiting
9,600 enrolled
CCANED-CIPHER
Recruiting
6,000 enrolled
ELEPHAS-02
Recruiting
416 enrolled
LIBERATE
Recruiting
2,500 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
OvAR-Y
Recruiting
10 enrolled
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Recruiting
5,000 enrolled
PRIORITY
Completed
346 enrolled 9 charts
START
Terminated
10 enrolled
Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
Recruiting
1,200 enrolled
Tempus Priority Study: A Pan-tumor Observational Study
Active not recruiting
1,000 enrolled
SURVIMON
Active not recruiting
100,000 enrolled
LONGEVITI
Recruiting
75 enrolled
Genomic Testing and Resulting Medical Decisions
Completed
1,500 enrolled
PREFER
Completed
1,429 enrolled
INSPIRE
Recruiting
5,350 enrolled
MOHCCN-O
Recruiting
500 enrolled
ROOT
Completed
167 enrolled
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Withdrawn
QUANTUM
Enrolling by invitation
3,000 enrolled
Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
Completed
86 enrolled
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Completed
17,667 enrolled
CER
Recruiting
15,000 enrolled
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Unknown
2,700 enrolled
MORRIS
Completed
118 enrolled
Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars
Completed
16,506 enrolled
ELISA
Unknown
320 enrolled
Establishment of a Tumor Bank for Blood Samples
Recruiting
10,000 enrolled
Establishment of a Tumor Bank for Tissue Samples
Recruiting
10,000 enrolled
Guangzhou Women's Health Cohort Study (GWHCS)
Suspended
1,000,000 enrolled
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Unknown
3,000 enrolled
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Completed
5,133 enrolled
Taiwan Cancer Moonshot Project
Recruiting
4,190 enrolled
Validation of the Russian and Kazakh Versions of the Beck Depression Inventory and Beck Anxiety Inventory
Completed
226 enrolled
SPACE2
Unknown
150 enrolled
A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.
Unknown
200 enrolled
PIONEER
Unknown
1,000 enrolled